SCHEMBL19082132

SCHEMBL19082132

c1ccc2cc(-c3c4ccccc4c(-c4ccc5c(c4)sc4c5ccc5c6ccc7ccccc7c6sc54)c4ccccc34)ccc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 6/20 0.40
CYP1B1 Q16678 6/20 0.40
CYP1A2 P05177 5/20 0.40
MAPK9 P45984 1/20 0.35
MAPK14 Q16539 1/20 0.35
ALOX5 P09917 3/20 0.34
GSTP1 P09211 1/20 0.33
PDE9A O76083 1/20 0.33
ESR1 P03372 1/20 0.33
ESR2 Q92731 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HPRT1 P00492 1/20 0.32
GPR84 Q9NQS5 1/20 0.32
LIMK1 P53667 1/20 0.32
IKBKB O14920 1/20 0.32
NQO1 P15559 1/20 0.32
NQO2 P16083 1/20 0.32
ALDH1A1 P00352 1/20 0.32
CYP2C9 P11712 1/20 0.32
HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17247178 0.97 CYP1A1 (0.42) CYP1A1CYP1B1CYP1A2MAPK9MAPK14
SCHEMBL19082167 0.95 CYP1A1 (0.43) CYP1A1CYP1B1CYP1A2MAPK9MAPK14
SCHEMBL17944853 0.93 CYP1A1 (0.40) CYP1A1CYP1B1CYP1A2MAPK9MAPK14
SCHEMBL17247182 0.93 CYP1A1 (0.40) CYP1A1CYP1B1CYP1A2MAPK9MAPK14
SCHEMBL19082129 0.93 CYP1A1 (0.40) CYP1A1CYP1B1CYP1A2MAPK9MAPK14
SCHEMBL17247207 0.92 CYP1A1 (0.45) CYP1A1CYP1B1CYP1A2MAPK9MAPK14
SCHEMBL17247202 0.92 CYP1A1 (0.45) CYP1A1CYP1B1CYP1A2MAPK9MAPK14
SCHEMBL17247185 0.92 CYP1A1 (0.45) CYP1A1CYP1B1CYP1A2MAPK9MAPK14
SCHEMBL22218977 0.91 HPRT1 (0.40) CYP1A1CYP1B1CYP1A2MAPK9MAPK14
SCHEMBL17944600 0.91 ALOX5 (0.41) CYP1A1CYP1B1CYP1A2ALOX5GSTP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885CYP1A2 659/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885CYP1A2 659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.